DE68905929D1 - Aromatische ester und thioester, ihr herstellungsverfahren und ihre anwendung in der human- oder tiermedizin und in der kosmetik. - Google Patents

Aromatische ester und thioester, ihr herstellungsverfahren und ihre anwendung in der human- oder tiermedizin und in der kosmetik.

Info

Publication number
DE68905929D1
DE68905929D1 DE8989400162T DE68905929T DE68905929D1 DE 68905929 D1 DE68905929 D1 DE 68905929D1 DE 8989400162 T DE8989400162 T DE 8989400162T DE 68905929 T DE68905929 T DE 68905929T DE 68905929 D1 DE68905929 D1 DE 68905929D1
Authority
DE
Germany
Prior art keywords
thioesters
lower alkyl
aromatic esters
human
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989400162T
Other languages
English (en)
Other versions
DE68905929T2 (de
Inventor
Braham Villa Shroot
Jacques Eustache
Jean-Michel Bernardon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Centre International de Recherches Dermatologiques Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre International de Recherches Dermatologiques Galderma filed Critical Centre International de Recherches Dermatologiques Galderma
Publication of DE68905929D1 publication Critical patent/DE68905929D1/de
Application granted granted Critical
Publication of DE68905929T2 publication Critical patent/DE68905929T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8989400162T 1988-01-20 1989-01-19 Aromatische ester und thioester, ihr herstellungsverfahren und ihre anwendung in der human- oder tiermedizin und in der kosmetik. Expired - Fee Related DE68905929T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU87109A LU87109A1 (fr) 1988-01-20 1988-01-20 Esters et thioesters aromatiques,leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique

Publications (2)

Publication Number Publication Date
DE68905929D1 true DE68905929D1 (de) 1993-05-19
DE68905929T2 DE68905929T2 (de) 1993-07-22

Family

ID=19731014

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989400162T Expired - Fee Related DE68905929T2 (de) 1988-01-20 1989-01-19 Aromatische ester und thioester, ihr herstellungsverfahren und ihre anwendung in der human- oder tiermedizin und in der kosmetik.

Country Status (16)

Country Link
US (1) US4925658A (de)
EP (1) EP0325540B1 (de)
JP (1) JP2753300B2 (de)
AT (1) ATE88175T1 (de)
AU (1) AU613445B2 (de)
CA (1) CA1338561C (de)
DE (1) DE68905929T2 (de)
DK (1) DK23189A (de)
ES (1) ES2054038T3 (de)
FI (1) FI93352C (de)
IE (1) IE68445B1 (de)
LU (1) LU87109A1 (de)
NO (1) NO170009C (de)
NZ (1) NZ227666A (de)
PT (1) PT89480B (de)
ZA (1) ZA89441B (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4448006A (en) 1981-05-28 1984-05-15 Donn Incorporated Grid ceiling structure and method of converting
FR2649977B1 (fr) * 1989-07-18 1991-10-04 Cird Esters bi-aromatiques, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FR2728166A1 (fr) 1994-12-19 1996-06-21 Oreal Composition topique contenant un antagoniste de substance p
FR2729854A1 (fr) 1995-01-26 1996-08-02 Oreal Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique
FR2741878B1 (fr) * 1995-12-01 1998-01-09 Cird Galderma Composes biaromatiques portant un groupement adamantyl en ortho, compositions pharmaceutiques et cosmetiques les contenant et utilisations
US20050113283A1 (en) * 2002-01-18 2005-05-26 David Solow-Cordero Methods of treating conditions associated with an EDG-4 receptor
US8158136B2 (en) 2004-08-18 2012-04-17 L'oréal Emulsification system for use in cosmetics
WO2006018024A2 (en) 2004-08-18 2006-02-23 Ace Aps Cosmetic and pharmaceutical compositions comprising ace inhibitors and/or angiotensin ii receptor antagonists
WO2006037922A1 (fr) * 2004-10-04 2006-04-13 L'oreal Composition cosmetique et/ou dermatologique pour peaux sensibles
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
FR2889808B1 (fr) 2005-08-17 2011-07-22 Oreal Utilisation de l'acide 8-hexadecene-1,16-dicarboxylique comme agent de soin destine a favoriser la cohesion de la couche cornee
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
FR2910320B1 (fr) 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
JP2011512164A (ja) 2007-02-20 2011-04-21 ガルデルマ・リサーチ・アンド・デヴェロップメント 皮膚内への治療物質の送達方法
FR2912651A1 (fr) 2007-02-21 2008-08-22 Oreal Emulsion e/h pour le soin de la peau.
FR2912917B1 (fr) 2007-02-26 2012-05-18 Oreal Milieu conditionne et ses utilisations
FR2918886B1 (fr) 2007-07-17 2010-01-08 Oreal Utilisation d'au moins un extrait bacterien cultive sur eau thermale pour le traitement des peaux, muqueuses et cuirs chevelus sensibles
FR2919501B1 (fr) * 2007-08-02 2010-12-31 Oreal Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees
WO2009031106A2 (en) * 2007-09-04 2009-03-12 L'oreal Use of a combination of hesperidin and of a microorganism for influencing the barrier function of the skin
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2920304B1 (fr) 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
FR2928542B1 (fr) * 2008-03-13 2011-12-09 Oreal Procede de maquillage des levres
FR2931661B1 (fr) 2008-05-30 2010-07-30 Galderma Res & Dev Nouvelles compositions depigmentantes sous forme d'une composition anhydre sans vaseline et sans elastomere comprenant un derive phenolique solubilise et un retinoide.
FR2940907B1 (fr) 2009-01-15 2011-03-04 Oreal Composition cosmetique ou dermatologique, comprenant un retinoide, un compose non phosphate a base d'adenosine et un polymere semi-cristallin
FR2942719B1 (fr) 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
WO2011010075A1 (fr) 2009-07-24 2011-01-27 L'oreal Utilisation d'un derive d'acide jasmonique en tant qu'agent apaisant
FR2953716B1 (fr) 2009-12-16 2015-03-27 Oreal Kit de formulation d'un produit cosmetique
FR2968952A1 (fr) 2010-12-17 2012-06-22 Oreal Ester d'acide amine n-acyle a titre d'agent apaisant
FR2981272A1 (fr) 2011-10-14 2013-04-19 Inneov Lab Utilisation d'une composition orale comprenant un melange d'au moins un polyphenol, de zinc, et de vitamine c.
JP6559958B2 (ja) 2012-04-11 2019-08-14 ロレアル 自立性美容シート
FR2996135A1 (fr) 2012-09-28 2014-04-04 Inneov Lab Composition orale pour renforcer la tolerance cutanee suite a une administration topique d'un compose retinoide.
EP2789369B1 (de) 2013-04-14 2018-06-06 Symrise AG Eine Zubereitung zur Aufhellung von Haut und Haaren
EP2842607B1 (de) 2013-09-02 2018-05-30 Symrise AG Eine Mischung zur Aufhellung von Haut und/oder Haaren
US10765621B2 (en) 2013-09-22 2020-09-08 Symrise Ag Extracts of halimione portulacoides and their application
EP2853254B1 (de) 2013-09-26 2017-11-08 Symrise AG Kosmetische Zusammensetzung zur Aufhellung von Haut und/oder Haaren
EP2859883B1 (de) 2013-10-13 2019-05-15 Symrise AG Mischungen von Aktivstoffen enthaltend acylierte Oligopeptide und Troxerutin
EP3062766A1 (de) 2013-10-29 2016-09-07 L'Oreal, S.A. Verwendung von mono-ornithin-ketoglutarat (mokg)
EP3443950A1 (de) 2014-07-30 2019-02-20 Symrise AG Prafümzubereitung
EP3023090B1 (de) 2014-11-21 2019-08-07 Symrise AG Zubereitungen
EP3045161B1 (de) 2015-01-18 2026-03-25 Symrise AG Verwendung von Wirkstoffgemischen aus 1,2-Hexandiol und 1,2-Octandiol in kosmetischen, pharmazeutischen oder dermatologischen Emulsionen
ES2933563T3 (es) 2015-04-16 2023-02-10 Symrise Ag Uso de una composición de liposoma
WO2016174011A1 (en) 2015-04-28 2016-11-03 Cutech Srl Compositions comprising valerian extracts
EP3097905B1 (de) 2015-05-28 2020-11-04 Symrise AG Kosmetische zubereitungen
EP3108941B1 (de) 2015-06-23 2018-05-09 Symrise AG Zubereitungen enthaltend polyalkylenglykol-derivate
WO2017041834A1 (en) 2015-09-08 2017-03-16 Symrise Ag Fragrance mixtures
EP3367994B1 (de) 2015-10-28 2021-05-12 Symrise AG Verfahren zur unterdrückung oder maskierung von fischgerüchen
EP3373895B1 (de) 2015-11-15 2020-08-19 Symrise AG Verminderung eines brennenden gefühls auf der haut
WO2017097434A1 (en) 2015-12-06 2017-06-15 Symrise Ag A fragrance composition
WO2017167364A1 (en) 2016-03-30 2017-10-05 Symrise Ag An active mixture
EP3500236A1 (de) 2016-08-20 2019-06-26 Symrise AG Konservierende mischung
JP7441042B2 (ja) 2016-12-02 2024-02-29 シムライズ アーゲー 化粧品ブレンド
FR3061002B1 (fr) 2016-12-23 2019-05-24 L'oreal Composition comprenant de l’acide hydroxyethylpiperazine ethane sulfonique et au moins un alkylpolyglucoside
IT201700090929A1 (it) 2017-08-07 2019-02-07 Cutech S R L Usi cosmetici e medici di estratti del fungo Coprinus comatus per la regolazione dell’unità pilo sebacea.
WO2019029808A1 (en) 2017-08-09 2019-02-14 Symrise Ag 1,2-ALKANEDIOLS AND PROCESSES FOR PRODUCING THE SAME
DE202017007679U1 (de) 2017-08-09 2024-03-15 Symrise Ag 1,2-Alkandiole
JP7213260B2 (ja) 2018-03-08 2023-01-26 シムライズ アーゲー 人間の皮膚および／または髪の治療のための混合物
US12403076B2 (en) 2018-09-20 2025-09-02 Symrise Ag Compositions comprising odorless 1,2-pentanediol
AU2019434303B2 (en) 2019-03-12 2024-11-14 Symrise Ag An antimicrobial mixture
WO2021195931A1 (en) 2020-03-31 2021-10-07 L'oreal Cosmetic composition in the form of a gel
CN116490160A (zh) 2020-12-09 2023-07-25 西姆莱斯股份公司 一种含有1,2-链烷二醇的混合物
FR3126311B1 (fr) 2021-08-27 2024-12-20 Oreal Procede cosmetique non therapeutique pour reduire les rides sur une surface de la peau, kit pour la mise en œuvre du procede, et procede d’utilisation d’un kit
US20240350394A1 (en) 2021-07-16 2024-10-24 L'oreal A non-therapeutic cosmetic method for reducing wrinkles on a skin surface
EP4452190A1 (de) 2021-12-20 2024-10-30 L'oreal Stabile zusammensetzung mit retinoid und ascorbinsäureverbindung
WO2023120259A1 (en) 2021-12-20 2023-06-29 Oreal Stable composition comprising retinoid
FR3131837B1 (fr) 2022-01-19 2024-10-04 Oreal Composition stable comprenant un rétinoïde et un composé acide ascorbique
FR3131845B1 (fr) 2022-01-19 2024-11-01 Oreal Composition stable comprenant un rétinoïde
CN119654146A (zh) 2022-08-31 2025-03-18 莱雅公司 用于护理角蛋白材料的组合物和包含它的敷膜
FR3145278B1 (fr) 2023-01-30 2026-04-10 Oreal Composition de dispersion stable comprenant un rétinoïde
WO2024135577A1 (en) 2022-12-23 2024-06-27 L'oreal Stable dispersion composition comprising retinoid
FR3148912B1 (fr) 2023-05-24 2026-02-20 Oreal Composition comprenant des polymères cationiques et anioniques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1290848A (de) * 1968-11-11 1972-09-27
US4051104A (en) * 1972-12-26 1977-09-27 Ciba-Geigy Corporation Benzoyloxybenzoates and compositions stabilized therewith
CH586728A5 (de) * 1972-12-26 1977-04-15 Ciba Geigy Ag

Also Published As

Publication number Publication date
ES2054038T3 (es) 1994-08-01
EP0325540B1 (de) 1993-04-14
NZ227666A (en) 1991-04-26
DK23189D0 (da) 1989-01-19
JP2753300B2 (ja) 1998-05-18
JPH029841A (ja) 1990-01-12
US4925658A (en) 1990-05-15
AU613445B2 (en) 1991-08-01
LU87109A1 (fr) 1989-08-30
ATE88175T1 (de) 1993-04-15
CA1338561C (fr) 1996-08-27
AU2860889A (en) 1989-07-20
ZA89441B (en) 1989-10-25
NO170009C (no) 1992-09-02
EP0325540A1 (de) 1989-07-26
FI93352C (fi) 1995-03-27
NO890252L (no) 1989-07-21
IE890152L (en) 1989-07-20
PT89480B (pt) 1994-08-31
FI93352B (fi) 1994-12-15
FI890291A0 (fi) 1989-01-19
FI890291A7 (fi) 1989-07-21
IE68445B1 (en) 1996-06-12
PT89480A (pt) 1989-10-04
NO170009B (no) 1992-05-25
DK23189A (da) 1989-07-21
NO890252D0 (no) 1989-01-19
DE68905929T2 (de) 1993-07-22

Similar Documents

Publication Publication Date Title
DE68905929D1 (de) Aromatische ester und thioester, ihr herstellungsverfahren und ihre anwendung in der human- oder tiermedizin und in der kosmetik.
NZ240189A (en) Aryl substituted amides, carbamates, carbonates, ketones and esters; preparation and pharmaceutical/cosmetic compositions thereof
SE8800949D0 (sv) Aromatiska karboxylsyraderivat och anvendning av dessa som mellanprodukter for framstellning av aromatiska heterocykliska derivat med terapeutiska och kosmetiska egenskaper
AU7590387A (en) Novel bicyclic aromatic derivatives, method for preparing them, and their use in human and veterinary medicine and in cosmetics
PT82361B (pt) Processo para a preparacao de derivados benzonaftalenicos e sua utilizacao nos dominios farmaceuticos e cosmetico
DE69204084D1 (de) Glycyl-Serine Amide und diese enthaltende kosmetische und pharmazeutische Zusammensetzungen oder Röhrmittel.
NO302523B1 (no) Heterosykliske forbindelser, farmasöytiske preparater som omfatter dem, og anvendelse av forbindelsene for fremstilling av medikamenter
GR890300124T1 (en) Polycyclic heterocyclic derivatives, proces for their preparation and their use in human and veterinary medicines
FR2713637B1 (fr) Nouveaux composés bi-aromatiques dérivés d'amide, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
DE69001515D1 (de) Urethan-derivate, ihre herstellung und verwendung als hautbefeuchtendes mittel in kosmetischen und pharmazeutischen zubereitungen zur behandlung trockener haut.
ES2129112T3 (es) Compuestos aromaticos policiclicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
KR910700230A (ko) 신규 히드록실아민 유도체
ZA893474B (en) Sulphur-containing eicosanoides and their application in pharmacy and in cosmetics
DE58904337D1 (de) Arzneimittel enthaltend nitroxyalkylamine mit amidfunktion und verfahren zur herstellung dieser verbindungen.
DE69015787D1 (de) Thiophenderivate, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
ATE110568T1 (de) Pharmazeutisches präparat zur behandlung des katarakts.
ATE22555T1 (de) Mercaptoessigsaeure und 3-mercaptopropionsaeureamidderivate fuer ihre verwendung bei der therapeutischen behandlung von menschlichen oder tierischen koerpern, einige neue derivate und diese enthaltende pharmazeutische zusammensetzungen.
ATE66920T1 (de) Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten.
ATE181503T1 (de) Verwendung von idazoxan und derivaten zur herstellung eines arzneimittels zur behandlung von parkinsonismus und seiner evolution
DE69008762D1 (de) Retinsäureester von l-Cladinos, Verfahren zu deren Herstellung und ihre Verwendung in der Human- oder Veterinärmedizin und in der Kosmetik.
DE69008761D1 (de) Retinsäureester von D-Desosamin, Verfahren zu deren Herstellung und ihre Verwendung in der Human- oder Veterinärmedizin und in der Kosmetik.
KR910002787A (ko) 아크릴산 아미드유도체, 이들의 제조방법, 이들을 함유하는 약리학적 조성물 및 이들을 사용하는 약품

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee